Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Global Antibiotics Market by Product Type (Cephalosporins, Penicillins, Fluroquinilones, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides) by Spectrum (Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics) – Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Antibiotics Market was valued at USD XX Billion in the year 2017. Global Antibiotics Market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX Billion by the year 2023.

Asia Pacific region holds the highest market share in 2017 and is considered as the fastest growing market in the forecasted period. At the country level India and China are the major markets and holds a substantial market share in 2017 and it is projected to grow at a gradual pace in the coming years. The Asia Pacific on account of its huge population base, the high prevalence of infectious diseases, regulation reforms, and greater use of generic medicines held a commanding share in 2017.

The Antibiotics market is segmented on the basis of type, spectrum, and region. By product type, in the global antibiotic market Cephalosporins was the largest type segment of the Antibiotics market in 2017 and is expected to grow with XX% CAGR in coming years. Based on the spectrum, it is classified into Broad-Spectrum Antibiotics and Narrow-Spectrum Antibiotics.

Drivers:

            The emergence of Anti-MRSA/VRE Drugs

Restraints:

            Antibiotic Resistance

Opportunities:

            Development of Generic Drugs

Challenges:

            Time Taken for Regulatory Approval 

GlaxoSmithKline (U.K), Johnson & Johnson (U.S), Merck (U.S), Pfizer (U.S), AstraZeneca (U.K), Bayer Healthcare AG (Germany), Novartis (Switzerland), Sanofi (France), Abbott Laboratories (U.S), and Roche (Switzerland), among others are some of the key players in the Global Antibiotics Market.

Key Benefits for Stakeholders

Pharmaceutical Manufacturers

Healthcare Product Distributors

Research and Development (R&D) Companies

Government Associations

Market Research and Consulting Firms

By Product Type

Cephalosporins

Penicillins

Fluroquinilones

Macrolides

Carbapenems

Aminoglycosides

Sulfonamides

Others

By Spectrum

Broad-Spectrum Antibiotics

Narrow-Spectrum Antibiotics

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

GlaxoSmithKline

Johnson & Johnson

Merck

Pfizer

Astrazeneca

Bayer Healthcare AG

Novartis

Sanofi

Abbott Laboratories

Roche 

(Another brief information of 10 companies will be provided in the report.)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Global Antibiotics Market, By Product Type

6.1 Cephalosporins

6.2 Penicillins

6.3 Fluroquinilones

6.4 Macrolides

6.5 Carbapenems

6.6 Aminoglycosides

6.7 Sulfonamides

6.8 Others

7. Global Antibiotics Market, By Spectrum

7.1 Broad-Spectrum Antibiotics

7.2 Narrow-Spectrum Antibiotics

8. Geographical Analysis

8.1. Introduction

8.2. North America

       8.2.1. U.S.

       8.2.2. Canada

       8.2.3. Mexico

8.3. Europe

       8.3.1. U.K.

       8.3.2. Germany

       8.3.3. Italy

       8.3.4. France

       8.3.5. RoE

8.4. Asia Pacific

       8.4.1. South Korea

       8.4.2. China

       8.4.3. Japan

       8.4.4. South Korea

       8.4.5. RoAPAC

8.5. RoW

       8.5.1. Latin America

       8.5.2. Middle East and Africa

9. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

9.1 GlaxoSmithKline

9.2 Johnson & Johnson

9.3 Merck

9.4 Pfizer

9.5 Astrazeneca

9.6 Bayer Healthcare AG

9.7 Novartis

9.8 Sanofi

9.9 Abbott Laboratories

9.10 Roche

(Another brief information of 10 companies will be provided in the report.)

10. Competitive Analysis

10.1. Introduction

10.2. Market Positioning of Key Players

10.3 Competitive Strategies Adopted by Leading Players

        10.3.1. Investments & Expansions

        10.3.2. New Product Launches

        10.3.3. Mergers & Acquisitions

        10.3.4. Agreements, Joint Ventures, and Partnerships

11. Appendix

11.1. Questionnaire

11.2. Available Customizations 

11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

* The list of tables and figures will be provided in the sample report.

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports